Los casos de VIH en Rusia alcanzan un récord que supera el millón

Noticias

Los casos de VIH en Rusia alcanzan un récord que supera el millón

17 febrero 2016

Rusia se encuentra ante un peligro inminente y podría pasar de una situación de ‘epidemia concentrada’ de VIH, en que el virus está confinado a un sector específico de la población, a una situación de ‘epidemia generalizada’, en que el virus prolifera entre la sociedad más amplia. Más información, en inglés, está disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas.

By Matt Broomfield

More than a million Russians are now HIV-positive, as rates of infection in the country reach an all-time high.

Vadim Pokrovsky, the head of the Russian state Aids centre and an outspoken critic of the Kremlin's conservative health policies, told Reuters that at at least 1 million and possibly as many as 1.5 million Russians were now HIV-positive.

This means that a little over 1 per cent of Russia's 144,000,000 inhabitants now test positive for the virus, meaning that Russia has more cases of HIV per person than any other European country, save Estonia. By way of contrast, there are only around 100,000 individuals in the UK living with HIV.

“The epidemic is gathering strength," Mr Pokrovsky added. "Unfortunately, the measures that have been taken have clearly not been enough.”

There were 90,000 new cases in Russia in 2014, and the Aids centre further estimate that the number of HIV infections will reach 2 million by 2019. Since Russia's first recorded case of HIV in 1987, around 204,000 people have died as a result of the virus. 57 per cent of Russians infected with the virus acquired it through drug use, with around 20 per cent of the country's large number of known drug users testing positive for the disease. Russia has the largest number of intravenous drug users in the world – 1.8 million of them, according to a 2012 Lancet study. Only around 30 per cent of Russians diagnosed with HIV currently receive the antriretroviral medication that their bodies need to stop the virus from multiplying.

Click here to read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.

Thumbnail: Wikipedia